Sun Pharmaceutical Industries Limited (SUNPHARMA): research summary

Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for Sun Pharmaceutical Industries Limited, explained in plain English.

• ▪Sun Pharmaceutical Industries Limited is tracked in the Pharma & Healthcare sector of the NSE universe covered here.
• ▪SUNPHARMA closed at ₹1,761.00 on 29 October 2026.
• ▪Over the past year the shares are up 2.6%, trading between ₹1,583.70 and ₹2,046.90.
• ▪Reported fundamentals show a net margin of 20.19%, debt to equity of 5.52.
• ▪Our transparent MaxGrade checklist scores it D (41/100) across momentum, growth, profitability and safety, using Pharma & Healthcare sector medians as the bar.
• ▪Annualised volatility over the past year is 19.24% with a maximum drawdown of -13.23% and a beta of 0.45 against NIFTY 50.
• ▪Recent coverage: Stocks To Watch Today: Dixon Tech, Syrma SGS, Sun Pharma, Wipro, Trent Among Others
• ▪Recent coverage: Sun Pharma falls short of bond fundraising target amid rising yields
• ▪Recent coverage: Sun Pharma raises ₹78.16 billion through two five-year bond issues

Other Pharma & Healthcare companies: Abbott India, Acutaas Chemicals, Ajanta Pharmaceuticals, Alkem Laboratories, Anthem Biosciences, Apollo Hospitals Enterprise, Aster DM Quality Care, Aurobindo Pharma

Last traded values from 29 Oct 2026. Market opens at 9:15 IST.